Contents
Download PDF
pdf Download XML
390096 Views
30874 Downloads
Share this article
Research Article | Volume 25 Issue 1 (, 2019) | Pages 62 - 65
Triple Percutaneous Mitral Balloon Valvuloplasty for Patients with Recurrent Mitral Valve Stenosis: Long-Term Observations
 ,
 ,
 ,
 ,
 ,
 ,
 ,
1
Department of Interventional Cardiology and Angiology, Institute of Cardiology, Warsaw, Poland.
2
Department of Congenital Cardiac Defects, Institute of Cardiology, Warsaw, Poland.
Under a Creative Commons license
PMID : -27989086
Published
Jan. 11, 2016
Abstract

Background: A third percutaneous mitral balloon valvuloplasty (PMBV) may provide a means of treating symptomatic patients with re-restenosis after successful initial and second valvuloplasties, though data related to the long-term safety and efficacy of a third PMBV are lacking. The study aim was to determine the immediate and long-term clinical outcome in patients who underwent a third PMBV to treat recurrent mitral stenosis.

Methods: Among a total of 1,849 patients who underwent PMBV at the authors' institution, seven females (mean age 38.5 ± 12.2 years at the first procedure) required repeat second and third PMBVs. The mean interval between the first and second valvuloplasties was 6.4 ± 2.5 years, and between the first and third valvuloplasties was 12.5 ± 6.5 years. All procedures were performed using the Inoue balloon system.

Results: Second and third PMBVs resulted in a significant increase in mitral valve area (MVA), from 1.1 ± 0.1 cm2 to 1.6 ± 0.2 cm2, and from 1.0 ± 0.2 cm2 to 1.6 ± 0.4 cm2, respectively. However, as mitral degeneration progressed, four patients required mitral valve replacement (MVR) at 9.2 ± 5.8 years (range: 6-18 years) after the third PMBV. The preoperative MVA of these patients was 0.97 ± 0.1 cm2. One patient died due to surgical complications, while the fifth and sixth patients remain under clinical observation. If patients have a fourth recurrence of mitral stenosis they are no longer considered to be suitable candidates for re-PMBV. The seventh patient died at the age of 84 years.

Conclusions: A repeat, third PMBV is a safe and feasible procedure in selected patients with recurrent stenosis after successful first and second valvuloplasties. Although the third procedure provides good immediate results, the long-term outcome is not satisfactory. Nonetheless, a third PMBV would allow MVR surgery to be postponed for a few years.

 

 

 

How to cite: Tyczyński, P., Chmielak, Z., Rużyłło, W., Fronczak, A., Kłopotowski, M., Szymański, P., Konka, M., & Witkowski, A. (2016). Triple Percutaneous Mitral Balloon Valvuloplasty for Patients with Recurrent Mitral Valve Stenosis: Long-Term Observations. The Journal of heart valve disease25(1), 62–65.

 
Keywords
Recommended Articles
Research Article
Morphological and Morphometric Study of Fossa Ovalis in Cadaveric Human Hearts with its Embryological Basis and Clinical Implications
...
Published: 29/12/2025
Download PDF
Read Article
Research Article
The efficacy of liposomal bupivacaine compared with traditional peri-articular injection for pain control following total knee arthroplasty
Published: 24/09/2016
Download PDF
Read Article
Research Article
Evaluation of Use of Indocyanine Green Fluorescence Cholangiography In Laparoscopic Cholecystectomy
Published: 03/04/2026
Download PDF
Read Article
Research Article
Prevalence and Identification of Risk Factors for Knee Osteoarthritis among Elderly Population
Published: 30/08/2016
Download PDF
Read Article
© Copyright Journal of Heart Valve Disease